Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

liver, lung and lymph node metastases. The duration of response, independently reviewed, ranged from 7.1 weeks to 30.0 weeks. The median time to progression in the treated population was 5.9 weeks. The adverse events were manageable, predictable and consistent with those seen in the Phase I trials of ispinesib. The most common grade 3/4 adverse events observed were neutropenia, febrile neutropenia and neutropenic sepsis.

In addition, GSK has sponsored three dose-escalating Phase Ib clinical trials. Each of these clinical trials was designed to evaluate the safety, tolerability and pharmacokinetics of ispinesib in combination with a leading anti-cancer therapeutic, one in combination with carboplatin, the second in combination with capecitabine, and the third in combination with docetaxel. The clinical trial evaluating ispinesib in combination with capecitabine is closed to enrollment. Final data from this trial are expected in 2007.

Under a November 2006 amendment to its collaboration and license agreement with GSK, Cytokinetics has assumed responsibility for the costs and activities associated with the continued development of the KSP inhibitors, ispinesib and SB-743921, subject to GSK s option to resume responsibility for some or all development and commercialization activities associated with each of these novel drug candidates. Cytokinetics plans to conduct, at its expense, a focused development program for ispinesib in breast cancer specifically designed to supplement the broad series of Phase I and Phase II clinical trials sponsored by GSK that have demonstrated clinical activity in the treatment of patients with metastatic breast cancer and that have shown an acceptable tolerability profile for ispinesib in combination with standard chemotherapeutics.

The NCI has sponsored six additional Phase II clinical trials, evaluating the potential efficacy of ispinesib in an array of different tumor types. Enrollment has been closed for
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:7/4/2015)... , Spanje, July 4, 2015 /PRNewswire/ ... Y-90 harsmicrosferen aan eerstelijns chemotherapie voor patiënten ... lever (mCRC) verlengt de progressievrije overleving in ... niet-resectabele, gemetastaseerde colorectale kanker (mCRC) die alleen ... verbetering gezien in progressievrije overleving (PFS) in ...
(Date:7/3/2015)... 2015 According to a ... Rhythm Management Market ECG, Implantable Loop Recorder, Manual ... Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P - Global ... Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) ... by 2020 from $21,137.7 Million in 2015, at ...
(Date:7/3/2015)... July 3, 2015  Obsidian HDS, the developer of ... service for the management of data on pharmaceutical and ... PharmaShine now includes the 2014 Open Payments General and ... on June 30. The data disclosed on Open Payments ... industry and providers totaling $6.49 billion and is the ...
Breaking Medicine Technology:Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... CVS Caremark Corporation (NYSE: CVS ) ... 3, 2011, at 8:30 a.m. (ET) with analysts and ... as well as its initial guidance for 2011. ... the conference call will be broadcast simultaneously through the ...
... the stethoscope for the 21st century. Ultrasound is ... patients quickly and accurately. It,s been around for decades, but ... years, making the machines smaller, cheaper and smarter. ... making its own mark with ultrasound. It,s the only medical ...
Cached Medicine Technology:U of South Carolina, a Leader in Ultrasound Education, Hosts World Congress in Spring 2U of South Carolina, a Leader in Ultrasound Education, Hosts World Congress in Spring 3
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift of poetry ... sat down to write his first poem, and three years later he was publishing an ... and worth sharing with the world. "I have always believed that the best way to ...
(Date:7/2/2015)... , ... July 02, 2015 , ... As Americans celebrate ... the hot temps, skin cancer is on the rise. July is UV Safety Month, ... raising awareness about the importance of getting skin checks. Experts say most skin cancers ...
(Date:7/2/2015)... CITY, GA (PRWEB) , ... July 02, 2015 , ... ... their newest innovation in compression socks designed for men. , For style that’s ... socks into their daily routine. This is great news for men everywhere because a ...
(Date:7/2/2015)... ... 02, 2015 , ... The ZAC Foundation, a national leader in water safety ... on how to stay water safe with the help of a young polar bear ... ZAC Foundation co-founders, follows Zeke’s water safety journey. Zeke, who is afraid of ...
Breaking Medicine News(10 mins):Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3
... transient neurological attacks, such as temporary amnesia or ... and dementia, according to a study in the ... neurological attacks (TNAs) are episodes involving temporary (less ... be nonfocal (that can include nonlocalizing cerebral symptoms), ...
... Early practice for youngsters can reduce risk of shoulder ... News) -- Playing catch with your young pitcher months before ... pitfall: torn rotator cuff injuries, according to doctors at Methodist ... - a high pitch count and throwing curve balls -- ...
... are among those that pose a threat, experts warn ... lead in toys has attracted a great deal of attention ... may pose to children. For example, some toys can damage ... There were more than 210,000 toy-related injuries treated in U.S. ...
... today announced that it has received a letter from ... bid price of the Company,s common,stock has closed below ... Marketplace Rule 4310(c)(4) (the "Rule").,Therefore, in accordance with Marketplace ... calendar days, or until June 16, 2008 to regain,compliance. ...
... 24 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: CHDX ... and products in the People,s Republic of China, ... the listing of its common stock on,the NASDAQ ... NASDAQ Capital,Market to the NASDAQ Global Market has ...
... PALM BEACH, Fla., Dec. 24 Veterans Affairs Medical,Center ... that could help reduce,the spiraling cost of healthcare nationwide., ... the area to adopt a privacy,curtain for hospital beds ... less maintenance than conventional hospital bed curtains. The,innovation called ...
Cached Medicine News:Health News:Some types of temporary neurological problems associated with increased risk for stroke, dementia 2Health News:Some types of temporary neurological problems associated with increased risk for stroke, dementia 3Health News:Playing Catch in Winter Could Save Kids' Pitching Arms 2Health News:Beware Holiday Toys That Can Injure Young Eyes 2Health News:QMed, Inc. Receives NASDAQ Letter 2Health News:Chindex International, Inc. Announces Transfer to NASDAQ Global Market 2Health News:Chindex International, Inc. Announces Transfer to NASDAQ Global Market 3Health News:VA Hospital Draws Curtain on Innovation That Could Help Reduce Spiraling Cost of Hospital Maintenance Nationwide 2
... Used for stone manipulation ... urinary tract. Enhanced wire ... dilation in the ureter. ... easy, ergonomic one-handed operation. ...
... Used for soft-tissue ... limited to paravaginal repairs, ... or rectocele. Surgisis® ES ... enhanced strength for intraoperative ...
... Used to provide drainage following open ... are employed to provide enhanced drainage ... provides maximum softness for enhanced patient ... to latex catheters. Supplied sterile in ...
... Reflotron Plus Chemistry Analyzer is an in ... determination of clinical chemistry parameters using Reflotron Test ... photometry and ensures rapid and reliable results while ... a clear LC display and the profile can ...
Medicine Products: